Genomics, Transcriptional Profiling, and Heart Failure

Journal of the American College of Cardiology

Volumn 53, Issue 19, 2009, Pages 1752-1759

  Margulies, Kenneth B ^a   Bednarik, Daniel P ^b   Dries, Daniel L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Cardiome Pharma Corp   (Canada)

Author keywords

genomics; heart failure; transcription

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL; DNA; ISOPROTEIN; MESSENGER RNA;

ALLELE; CARDIOMYOPATHY; CLINICAL TRIAL; DNA SCREENING; DRUG RESPONSE; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE MUTATION; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENOME; GENOMICS; GENOTYPE; HEART FAILURE; HEMODYNAMICS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOMYOPATHIES; DNA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMICS; HEART FAILURE; HUMANS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOMICS; RNA; RNA, MESSENGER;

EID: 65349121886     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.064     Document Type: Review

References (61)

1. Guttmacher A.E., and Collins F.S. Genomic medicine-a primer. N Engl J Med 347 (2002) 1512-1520
2. Khoury M.J. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 5 (2003) 261-268
3. Alcalai R., Seidman J.G., and Seidman C.E. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 19 (2008) 104-110
4. Bowles K.R., and Bowles N.E. Genetics of inherited cardiomyopathies. Expert Rev Cardiovasc Ther 2 (2004) 683-697
5. Li J., Zhu X., Chen M., et al. Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc Natl Acad Sci USA 102 (2005) 8916-8921
6. Dries D.L., Victor R.G., Rame J.E., et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112 (2005) 2403-2410
7. Rame J.E., Drazner M.H., Post W., et al. Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension 49 (2007) 857-864
8. Damani S.B., and Topol E.J. Future use of genomics in coronary artery disease. J Am Coll Cardiol 50 (2007) 1933-1940
9. Tang Z., McGowan B.S., Huber S.A., et al. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J Mol Cell Cardiol 36 (2004) 515-530
10. Hannenhalli S., Putt M.E., Gilmore J.M., et al. Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 114 (2006) 1269-1276
11. Aronow B.J., Toyokawa T., Canning A., et al. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genomics 6 (2001) 19-28
12. Kaneda R., Takada S., Yamashita Y., et al. Genome-wide histone methylation profile for heart failure. Genes Cells 14 (2009) 69-77
13. Kaneda R., Ueno S., Yamashita Y., et al. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes. Circ Res 97 (2005) 210-218
14. Olson E.N., Backs J., and McKinsey T.A. Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation. Novartis Found Symp 274 (2006) 3-12 discussion 13-9, 152-5, 272-6.
15. Fehlbaum P., Guihal C., Bracco L., and Cochet O. A microarray configuration to quantify expression levels and relative abundance of splice variants. Nucleic Acids Res 33 (2005) 47
16. Girolami F., Olivotto I., Passerini I., et al. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. J Cardiovasc Med (Hagerstown) 7 (2006) 601-607
17. Maass A.H., Ikeda K., Oberdorf-Maass S., Maier S.K., and Leinwand L.A. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation 110 (2004) 2102-2109
18. Omori K., and Kotera J. Overview of PDEs and their regulation. Circ Res 100 (2007) 309-327
19. Rose J., Armoundas A.A., Tian Y., et al. Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Am J Physiol Heart Circ Physiol 288 (2005) H2077-H2087
20. Qiu H., Dai H., Jain K., et al. Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure. J Biol Chem 283 (2008) 22157-22165
21. Einstein R., Jordan H., Zhou W., Brenner M., Moses E.G., and Liggett S.B. Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors. Proc Natl Acad Sci U S A 105 (2008) 5230-5235
22. Bracco L., Throo E., Cochet O., Einstein R., and Maurier F. Methods and platforms for the quantification of splice variants' expression. Prog Mol Subcell Biol 44 (2006) 1-25
23. Boyd S.D. Everything you wanted to know about small RNA but were afraid to ask. Lab Invest 88 (2008) 569-578
24. van Rooij E., Sutherland L.B., Liu N., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103 (2006) 18255-18260
25. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., and Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007) 575-579
26. Care A., Catalucci D., Felicetti F., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13 (2007) 613-618
27. Michels M., Hoedemaekers Y.M., Kofflard M.J., et al. Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J 15 (2007) 184-190
28. Havndrup O., Bundgaard H., Andersen P.S., et al. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res 57 (2003) 347-357
29. Ho C.Y., and Seidman C.E. A contemporary approach to hypertrophic cardiomyopathy. Circulation 113 (2006) 858-862
30. Zhang X.P., Kelemen S.E., and Eisen H.J. Quantitative assessment of cell adhesion molecule gene expression in endomyocardial biopsy specimens from cardiac transplant recipients using competitive polymerase chain reaction. Transplantation 70 (2000) 505-513
31. Shulzhenko N., Morgun A., Zheng X.X., et al. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. Transplantation 72 (2001) 1705-1708
32. Bayliss J., Maguire J.A., Bailey M., et al. Increased vascular endothelial growth factor mRNA in endomyocardial biopsies from allografts demonstrating severe acute rejection: a longitudinal study. Transpl Immunol 18 (2008) 264-274
33. Autieri M.V., Kelemen S., Thomas B.A., Feller E.D., Goldman B.I., and Eisen H.J. Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation 106 (2002) 2218-2223
34. Yousufuddin M., Haji S., Starling R.C., et al. Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation. Eur Heart J 25 (2004) 377-385
35. Horwitz P.A., Tsai E.J., Putt M.E., et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110 (2004) 3815-3821
36. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
37. Bernstein D., Williams G.E., Eisen H., et al. Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients. J Heart Lung Transplant 26 (2007) 1270-1280
38. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50 (2007) 1914-1931
39. Kittleson M.M., Minhas K.M., Irizarry R.A., et al. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21 (2005) 299-307
40. Kittleson M.M., Ye S.Q., Irizarry R.A., et al. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110 (2004) 3444-3451
41. Beisvag V., Lehre P.K., Midelfart H., et al. Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data. Eur J Heart Fail 8 (2006) 381-389
42. Huang X., Pan W., Grindle S., et al. A comparative study of discriminating human heart failure etiology using gene expression profiles. BMC Bioinformatics 6 (2005) 205
43. Wittchen F., Suckau L., Witt H., et al. Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med 85 (2007) 257-271
44. Kittleson M.M., Minhas K.M., Irizarry R.A., et al. Gene expression in giant cell myocarditis: altered expression of immune response genes. Int J Cardiol 102 (2005) 333-340
45. Heidecker B., Kasper E.K., Wittstein I.S., et al. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Circulation 118 (2008) 238-246
46. Steenman M., Lamirault G., Le Meur N., Le Cunff M., Escande D., and Leger J.J. Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur J Heart Fail 7 (2005) 157-165
47. Barrows B.R., Azimzadeh A.M., McCulle S.L., et al. Robust gene expression with amplified RNA from biopsy-sized human heart tissue. J Mol Cell Cardiol 42 (2007) 260-264
48. Damas J.K., Gullestad L., Aass H., et al. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure-modulatory effect of intravenous immunoglobulin. J Am Coll Cardiol 38 (2001) 187-193
49. Seiler P.U., Stypmann J., Breithardt G., and Schulze-Bahr E. Real-time RT-PCR for gene expression profiling in blood of heart failure patients-a pilot study: gene expression in blood of heart failure patients. Basic Res Cardiol 99 (2004) 230-238
50. Brown H.R., Ni H., Benavides G., et al. Correlation of simultaneous differential gene expression in the blood and heart with known mechanisms of adriamycin-induced cardiomyopathy in the rat. Toxicol Pathol 30 (2002) 452-469
51. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., and Wei W.I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14 (2008) 2588-2592
52. Liang Y., Ridzon D., Wong L., and Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8 (2007) 166
53. Jeyaseelan K., Lim K.Y., and Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39 (2008) 959-966
54. Mialet Perez J., Rathz D.A., Petrashevskaya N.N., et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9 (2003) 1300-1305
55. Liggett S.B., Mialet-Perez J., Thaneemit-Chen S., et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A 103 (2006) 11288-11293
56. McNamara D.M. Emerging role of pharmacogenomics in heart failure. Curr Opin Cardiol 23 (2008) 261-268
57. McNamara D.M., Tam S.W., Sabolinski M.L., et al. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. J Am Coll Cardiol 48 (2006) 1277-1282
58. Small K.M., Wagoner L.E., Levin A.M., Kardia S.L., and Liggett S.B. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347 (2002) 1135-1142
59. Liggett S.B., Cresci S., Kelly R.J., et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med 14 (2008) 510-517
60. Terra S.G., Pauly D.F., Lee C.R., et al. Beta-adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol Ther 77 (2005) 127-137
61. Wojnowski L., Kulle B., Schirmer M., et al. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 112 (2005) 3754-3762